Position in NTRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,290,560
+$1,435,553 QoQ
Shares Held
19,490
+1.1% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#257
of 844 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Pinnacle Financial Partners, Inc. holds $60,651,644 across 10 Diagnostics & Research names. NTRA ranks #4 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
37,906 | $19,004,551 | |
| 2 | DHR |
Danaher Corp /De/
|
79,360 | $15,116,491 | |
| 3 | LH |
Labcorp Holdings Inc.
|
41,291 | $11,561,480 | |
| 4 | NTRA |
Natera, Inc.
This page
|
19,490 | $5,290,560 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
2,616 | $3,341,966 | |
| 6 | DGX |
Quest Diagnostics Inc
|
12,687 | $2,689,009 | |
| 7 | VCYT |
Veracyte, Inc.
|
32,698 | $1,920,353 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
3,869 | $877,450 |
All Filings in NTRA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,290,560 | 19,490 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,855,007 | 19,276 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $4,430,829 | 19,341 | Shares | Defined | 2026-02-18 | |
| No filing history on record for this holder in this stock. | ||||||